Not logged in Trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory biomarker analysis of the randomized, phase 2 DESTINY-Gastric01 trial Shitara, Kohei; Bang, Yung-Jue; Iwasa, Satoru; Sugimoto, Naotoshi; Ryu, Min-Hee; Sakai, Daisuke; Chung, Hyun Cheol; Kawakami, Hisato; Yabusaki, Hiroshi; Sakamoto, Yasuhiro; Nishina, Tomohiro; Inaki, Koichiro; Kuwahara, Yusuke; Wada, Naoya; Suto, Fumitaka; Arita, Takeo; Sugihara, Masahiro; Tsuchihashi, Zenta; Saito, Kaku; Kojima, Akihito; Yamaguchi, Kensei Share Save
Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations Hertz, Daniel L.; Joerger, Markus; Bang, Yung-Jue; Mathijssen, Ron H.; Zhou, Caicun; Zhang, Li; Gandara, David; Stahl, Michael; Monk, Bradley J.; Jaehde, Ulrich; Beumer, Jan H. Share Save
Share Save
Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trial Shah, Manish A.; Shitara, Kohei; Ajani, Jaffer A.; Bang, Yung-Jue; Enzinger, Peter; Ilson, David; Lordick, Florian; Van Cutsem, Eric; Plazas, Javier Gallego; Huang, Jing; Shen, Lin; Oh, Sang Cheul; Sunpaweravong, Patrapim; Soo Hoo, Hwoei Fen; Turk, Haci Mehmet; Oh, Mok; Park, Jung Wook; Moran, Diarmuid; Bhattacharya, Pranob; Arozullah, Ahsan; Xu, Rui-Hua Share Save
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro- oesophageal junction adenocarcinoma (SPOTLIGHT) : a multicentre, randomised, double-blind, phase 3 trial Shitara, Kohei; Lordick, Florian; Bang, Yung-Jue; Enzinger, Peter; Ilson, David; Shah, Manish A.; Van Cutsem, Eric; Xu, Rui-Hua; Aprile, Giuseppe; Xu, Jianming; Chao, Joseph; Pazo-Cid, Roberto; Kang, Yoon-Koo; Yang, Jianning; Moran, Diarmuid; Bhattacharya, Pranob; Arozullah, Ahsan; Park, Jung Wook; Oh, Mok; Ajani, Jaffer A. Share Save
Tumor-agnostic efficacy and safety of dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: ROAR basket study Subbiah, Vivek; Kreitman, Robert J.; Wainberg, Zev A.; Gazzah, Anas; Lassen, Ulrik; Stein, Alexander; Wen, Patrick Y.; Dietrich, Sascha; Jonge, Maja J. A.; Blay, Jean-Yves; Italiano, Antoine; Yonemori, Kan; Cho, Daniel C.; de Vos, Filip Y. F. L.; Moreau, Philippe; Fernandez, Elena Elez; Schellens, Jan H.; Zielinski, Christoph C.; Redhu, Suman; Passos, Vanessa Q.; Ilankumaran, Palanichamy; Bang, Yung-Jue Share Save
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial Subbiah, Vivek; Kreitman, Robert J.; Wainberg, Zev A.; Gazzah, Anas; Lassen, Ulrik; Stein, Alexander; Wen, Patrick Y.; Dietrich, Sascha; de Jonge, Maja J. A.; Blay, Jean-Yves; Italiano, Antoine; Yonemori, Kan; Cho, Daniel C.; de Vos, Filip Y. F. L.; Moreau, Philippe; Fernandez, Elena Elez; Schellens, Jan H. M.; Zielinski, Christoph C.; Redhu, Suman; Boran, Aislyn; Passos, Vanessa Q.; Ilankumaran, Palanichamy; Bang, Yung-Jue Share Save
The signaling network of transforming growth factor β1, protein kinase Cδ, and integrin underlies the spreading and invasiveness of gastric carcinoma cells Lee, MS; Kim, TY; Kim, YB; Lee, SY; Ko, SG; Jong, HS; Kim, TY; Bang, YJ; Lee, JW Share Save
INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG) Lam, Lyn Ley; Pavlakis, Nick; Shitara, Kohei; Sjoquist, Katrin M.; Martin, Andrew J.; Yip, Sonia; Kang, Yoon-Koo; Bang, Yung-Jue; Chen, Li-Tzong; Moehler, Markus; Bekaii-Saab, Tanios; Alcindor, Thierry; O'Callaghan, Christopher J.; Tebbutt, Niall C.; Hague, Wendy; Chan, Howard; Rha, Sun Young; Lee, Keun-Wook; Gebski, Val; Jaworski, Anthony; Zalcberg, John; Price, Timothy; Simes, John; Goldstein, David Share Save
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors Kim, Tae Won; Burris, Howard A.; Luken, Maria J. de Miguel; Pishvaian, Michael J.; Bang, Yung-Jue; Gordon, Michael; Awada, Ahmad; Camidge, D. Ross; Hodi, F. Stephen; McArthur, Grant A.; Miller, Wilson H., Jr.; Cervantes, Andres; Chow, Laura Q.; Lesokhin, Alexander M.; Rutten, Annemie; Sznol, Mario; Rishipathak, Deepali; Chen, Shang-Chiung; Stefanich, Eric; Pourmohamad, Tony; Anderson, Maria; Kim, Jeong; Huseni, Mahrukh; Rhee, Ina; Siu, Lillian L. Share Save
Association of Tumor Mutational Burden with Efficacy of Pembrolizumab plus Chemotherapy as First-Line Therapy for Gastric Cancer in the Phase III KEYNOTE-062 Study Lee, Keun-Wook; Van Cutsem, Eric; Bang, Yung-Jue; Fuchs, Charles S.; Kudaba, Iveta; Garrido, Marcelo; Chung, Hyun Cheol; Lee, Jeeyun; Castro, Hugo R.; Chao, Joseph; Wainberg, Zev A.; Cao, Z. Alexander; Aurora-Garg, Deepti; Kobie, Julie; Cristescu, Razvan; Bhagia, Pooja; Shah, Sukrut; Tabernero, Josep; Shitara, Kohei; Wyrwicz, Lucjan Share Save
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma Shah, Manish A.; Shitara, Kohei; Lordick, Florian; Bang, Yung-Jue; Tebbutt, Niall C.; Metges, Jean-Phillippe; Muro, Kei; Lee, Keun-Wook; Shen, Lin; Tjulandin, Sergei; Hays, John L.; Starling, Naureen; Xu, Rui-Hua; Sturtz, Keren; Fontaine, Marilyn; Oh, Cindy; Brooks, Emily M.; Xu, Bo; Li, Wei; Li, Chiang J.; Borodyansky, Laura; Van Cutsem, Eric Share Save
Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061 (Aug, 10.1007/s10120-021-01200-w, 2021) Van Cutsem, Eric; Amonkar, Mayur; Fuchs, Charles S.; Alsina, Maria; Ozguroglu, Mustafa; Bang, Yung-Jue; Chung, Hyun Cheol; Muro, Kei; Goekkurt, Eray; Benson, Al B., III; Sun, Weijing; Wainberg, Zev A.; Norquist, Josephine M.; Chen, Xinqun; Shih, Chie-Schin; Shitara, Kohei Share Save
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial Fuchs, Charles S.; Ozguroglu, Mustafa; Bang, Yung-Jue; Di Bartolomeo, Maria; Mandala, Mario; Ryu, Min-Hee; Fornaro, Lorenzo; Olesinski, Tomasz; Caglevic, Christian; Chung, Hyun C.; Muro, Kei; Van Cutsem, Eric; Elme, Anneli; Thuss-Patience, Peter; Chau, Ian; Ohtsu, Atsushi; Bhagia, Pooja; Wang, Anran; Shih, Chie-Schin; Shitara, Kohei Share Save
Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061 Van Cutsem, Eric; Amonkar, Mayur; Fuchs, Charles S.; Alsina, Maria; Ozguroglu, Mustafa; Bang, Yung-Jue; Chung, Hyun Cheol; Muro, Kei; Goekkurt, Eray; Benson, Al B., III; Sun, Weijing; Wainberg, Zev A.; Norquist, Josephine M.; Chen, Xinqun; Shih, Chie-Schin; Shitara, Kohei Share Save
Quality of life with first-line pembrolizumab for PD-L1epositive advanced gastric/gastroesophageal junction adenocarcinoma: results from the randomised phase III KEYNOTE-062 study Van Cutsem, E.; Valderrama, A.; Bang, Y. -J.; Fuchs, C. S.; Shitara, K.; Janjigian, Y. Y.; Qin, S.; Larson, T. G.; Shankaran, V.; Stein, S.; Norquist, J. M.; Kher, U.; Shah, S.; Alsina, M. Share Save
Exploratory biomarker analysis of trastuzumab deruxtecan in DESTINY-Gastric01, a randomized, phase 2, multicenter, open-label study in patients with HER2-positive or -low advanced gastric or gastroesophageal junction adenocarcinoma Shitara, K.; Bang, Y.; Iwasa, S.; Sugimoto, N.; Ryu, M.; Sakai, D.; Chung, H.; Omuro, Y.; Kawakami, H.; Yabusaki, H.; Sakamoto, Y.; Nishina, T.; Inaki, K.; Kuwahara, Y.; Suto, F.; Sugihara, M.; Saito, K.; Kojima, A.; Yamaguchi, K. Share Save
Share Save
Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors Italiano, Antoine; Miller, Wilson H., Jr.; Blay, Jean-Yves; Gietema, Jourik A.; Bang, Yung-Jue; Mileshkin, Linda R.; Hirte, Hal W.; Higgins, Brian; Blotner, Steven; Nichols, Gwen L.; Chen, Lin Chi; Petry, Claire; Yang, Qi Joy; Schmitt, Christophe; Jamois, Candice; Siu, Lillian L. Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
